Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.300
-0.050 (-1.15%)
At close: Mar 6, 2026, 4:00 PM EST
4.387
+0.087 (2.02%)
After-hours: Mar 6, 2026, 7:24 PM EST
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $8.25 million as of March 6, 2026. Its market cap has decreased by -57.71% in one year.
Market Cap
8.25M
Enterprise Value
-67.40K
1-Year Change
-57.71%
Ranking
Category
Stock Price
$4.30
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $8.25M, a decrease of -98.80%. That is a compound annual growth rate of -58.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 8.25M | -21.36% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 9.08M |
| NuCana | 8.99M |
| TransCode Therapeutics | 8.80M |
| Iterum Therapeutics | 8.74M |
| CollPlant Biotechnologies | 8.73M |
| PharmaCyte Biotech | 8.08M |
| Alaunos Therapeutics | 8.06M |
| KALA BIO | 7.86M |